EWING SARCOMA IS RELENTLESS.
BUT SO ARE WE.

WHAT IS EWING SARCOMA?

Ewing Sarcoma is an aggressive form of bone cancer that typically affects kids and young adults. We have to find a lasting cure.

Common Questions About Ewing Sarcoma

Childhood Cancer Research is Grossly Underfunded

The National Cancer Institute (NCI) only spends an average of 3.94% of its research funding on all pediatric cancers combined or about 195 million dollars annually.

It may seem like a lot, but the US military spends $250,000,000 on The Military every day.

Ewing Sarcoma is just 1 of over 100 types of pediatric cancers.

Prostate cancer (average age at diagnosis, 66 years), receives more research funding from NCI than all childhood cancers combined (average age at diagnosis, 8-years-old).

A smiling young girl with a nasal tube decorated with heart-shaped ornaments, wearing a cardigan over a star-patterned dress, holding a small object in her hand.

The government is giving the LEAST to the population that has the MOST on the line.

Since 2003, our federal investment in pediatric clinical trials has declined every single year. Pediatric cancers are increasing, and we’re decreasing our investment.

Since 1980, only four drugs have been approved in the first instance for use in children. (Meaning the drugs were designed for pediatric use). None of those drugs are used in the standard Ewing Sarcoma protocol.

During this time, hundreds of drugs have been approved for adults. Only 7 of those have been approved for use in children, too.

A young boy sitting on a white Adirondack-style chair, wearing a Golden State Warriors basketball jersey, a cap with a Warriors logo, and sneakers. The boy is smiling. The background includes a pillow and part of a room with wooden flooring.

The standard treatment fails for too many kids.

For an adult with prostate cancer, if you have an adverse reaction to the standard chemo drugs, you have alternatives. If you find that the cancer isn’t responding to that drug, there’s an alternative.

For kids with unresponsive or relapsed Ewing Sarcoma, there isn’t a great alternative waiting in the wings.

Plan B is more of a blindfolded half-court shot. And that’s not good enough.

Every kid’s Ewings battle is now our battle too. And we won’t settle until their treatment is a slam dunk.

Young child lying in a hospital bed with a star-patterned pillow and pajamas, looking at a tablet. An IV line is attached to the child's arm, and there is crumpled clothing on a chair nearby.

Kids get the most toxic chemo available

The Ewings protocol includes some of the harshest and most toxic chemo drugs on the market including one known as the Red Devil (doxorubicin). It’s notoriously damaging to the heart. But this poison is the best we’ve got.

We’re grateful for the chemo drugs we have, truly. But it’s truly gut-wrenching to have to make your kid SO SICK to get them better.

As a Foundation, and as a family, we have particular interest in targeted (and humane) therapies that attack cancer cells, and that leave normal cells unharmed, such as Immunotherapy and Molecular Therapy.

A woman wearing a tank top and shorts, celebrating with arms raised, standing on a paved trail in a natural landscape with trees and mountains in the background, in black and white.

There is no finish line.

At least 25% of Ewing Sarcoma patients with initially localized disease will relapse after completing all planned therapy. The recurrence rate is 50-80% for patients with initially metastatic disease.

And if you can get Ewings to go away, and then stay away, survivors are still not out of the woods: More than 95% of childhood cancer survivors will have a significant health issue by the time they are 45 years old; these health-related issues are mostly commonly the side effects the harsh treatments.

While the current treatment may save some lives, it’s the same treatment that takes away their hair, their fertility, and their long-term health.

There’s got to be a better way. We truly believe it. And we’re hellbent on accelerating the research and development of a durable cure for Ewing Sarcoma and related sarcomas.

There’s hope on the horizon.

Immunotherapy and personalized medicine are transforming the treatment of many adult cancers. We’re focused on bringing these innovations directly to kids. They can’t wait.

What We’re Doing about it

SOURCES

NCI SPENDS 3.94%: National Cancer Institute, NIH/NCI Budget

MILITARY SPENDING: Newsweek: The Pentagon Spends $250 Million on War Everyday

COMPARATIVE STATS - PROSTATE CANCER:

DRUG APPROVALS:

RED DEVIL: The Oncology Nursing Society: Doxorubicin Is the Infamous Red Devil

RECURRENCE RATE: OncoTargets and Therapy: Management of recurrent Ewing sarcoma:challenges and approaches

HEALTH ISSUES: St. Jude Children’s Research Hospital, JAMA. 2013:309 [22]:2371-2381